Medytox Solutions, Inc. Watch

from 8-K 9 pages Amendment No. 4 to Senior Secured Revolving Credit Facility Agreementin the Amount of US$15,000,000 by and Among Medytox Solutions, Inc.,as Borrower, Medytox Medical Marketing & Sales, Inc.,biohealth Medical Laboratory, Inc.,advantage Reference Labs, Inc., Medytox Diagnostics, Inc.,pb Laboratories, Llc,alethea Laboratories, Inc., Andinternational Technologies, Llc,as Joint and Several Guarantors, and Tca Global Credit Master Fund, Lp,as Lender June 30, 2013 1 Amendment No. 4 to Senior Secured Revolving Credit Facility Agreement

from 8-K 3 pages Fourth Amended and Restated Revolving Promissory Note

from 8-K ~5 pages Amended and Restated Revolving Promissory Note

from 8-K 13 pages Amendment No. 3 to Senior Secured Revolving Credit Facility Agreementin the Amount of US$15,000,000 by and Among Medytox Solutions, Inc.,as Borrower, Medytox Medical Marketing & Sales, Inc.,biohealth Medical Laboratory, Inc.,advantage Reference Labs, Inc., Medytox Diagnostics, Inc., Andpb Laboratories, Llcas Joint and Several Guarantors, and Tca Global Credit Master Fund, Lp,as Lender February 28, 2013 1 Amendment No. 3 to Senior Secured Revolving Credit Facility Agreement

from 8-K 2 pages Amended and Restated Revolving Promissory Note

from 8-K 12 pages Amendment No. 2 to Senior Secured Revolving Credit Facility Agreement

from 8-K 2 pages Amended and Restated Revolving Promissory Note

from 8-K 13 pages Amendment No. 1 to Senior Secured Revolving Credit Facility Agreement

from 8-K/A ~5 pages The Securities Represented by This Certificate Have Not Been Registered Under the Securities Act of 1933, as Amended, or Applicable State Securities Laws. the Securities Have Been Acquired Solely for Investment Purposes and Not With a View Toward Resale and May Not Be Offered for Sale, Sold, Transferred or Assigned in the Absence of an Effective Registration Statement for the Securities Under the Securities Act of 1933, as Amended, or Applicable State Securities Laws, or an Opinion of Counsel, Acceptable to Borrower’s Counsel, That Registration Is Not Required Under Said Act or Applicable State Securities Laws. Revolving Promissory Note April 30, 2012 US $550,000

from 8-K/A >50 pages Senior Secured Revolving Credit Facility Agreement in the Amount of US$4,000,000 by and Among Medytox Solutions, Inc., as Borrower, Medytox Medical Marketing & Sales, Inc., Medytox Diagnostics, Inc., and Pb Laboratories, LLC as Joint and Several Guarantors, and Tca Global Credit Master Fund, LP, as Lender April 30, 2012 - 1